Infrainguinal revascularization after renal transplantation  by McArthur, Claudie S et al.
Infrainguinal revascularization after renal
transplantation
Claudie S. McArthur, MD, Malachi G. Sheahan, MD, Frank B. Pomposelli, Jr, MD, Andrea Dayko, BA,
Alana K. Belfield, BS, Jennifer Veraldi, BA, David R. Campbell, MD, John J. Skillman, MD, Frank W.
LoGerfo, MD, and Allen D. Hamdan, MD,* Boston, Mass
Background: Although evidence suggests that end-stage renal disease is associated with poor limb salvage and patient
survival after arterial revascularization, little is known about the effect of renal transplantation. We analyzed the outcome
in patients with renal transplants who underwent infrainguinal bypass procedures.
Methods: Data prospectively entered into our vascular registry were reviewed for all patients who underwent lower
extremity bypass procedures from January 1, 1990, through January 31, 2002. Sixty patients were identified who had a
functioning renal allograft at infrainguinal revascularization. Kaplan-Meier survival curves were generated for limb
salvage, patency, and patient survival and were compared with the Mantel-Cox log- rank test.
Results: Sixty patients (40 men, 20 women; mean age, 47.1 years) underwent 76 bypass procedures in 71 limbs.
Preoperative demographic data included diabetes (59 of 60 patients, 98.3%), coronary artery disease (26 of 60 patients,
43.3%), and preoperative serum creatinine concentration (SCr) greater than 2.0 mg/dL (9 of 60 patients, 11.7%). Mean
follow-up was 25.1 months. Overall major complication rate was 11.8%, and 30-day mortality rate was 1.3%. Survival was
93.3% at 1 year and 66.6% at 5 years. Limb salvage was 87% at 1 year and 78% at 5 years. Primary graft patency was 78%
at 1 year and 44% at 5 years. Preoperative SCr less than or equal to 2.0 mg/dL was associated with improved overall
patient survival (5-year survival, 73.4% vs 37.5%; P  .01, log-rank test). Limb salvage and patency rates were not
significantly affected by preoperative SCr greater than 2.0 mg/dL.
Conclusions: Lower extremity bypass can be performed safely and effectively in patients who have undergone renal
transplantation. However, the importance of a well-functioning renal allograft at surgery is demonstrated by marked
improvement in patient survival. (J Vasc Surg 2003;37:1181-5.)
Management of lower extremity ischemia in patients
with end-stage renal disease (ESRD) is not well-defined.
Life expectancy for patients with ESRD is significantly
lower than for age-matched control subjects1-4 with cardio-
vascular disease, accounting for 44% of overall mortality.5
Furthermore, outcome after lower extremity bypass to treat
arterial insufficiency in patients with renal failure is associ-
ated with inferior limb salvage and survival.6-9 Despite
increased cardiovascular morbidity in patients with ure-
mia,3,4 aggressive attempts at revascularization rather than
amputation have been recommended for treatment of
limb-threatening ischemia.10,11 The effect of renal trans-
plantation on surgical outcome after infrainguinal revascu-
larization is not known.
Renal transplantation has led to improved overall pa-
tient survival.1 Although renal transplant recipients are
generally younger than patients who undergo lower ex-
tremity bypass procedures,3 they have a relatively higher
incidence of comorbid conditions, including coronary ar-
tery disease, diabetes, and cerebrovascular disease3,12 that
may adversely affect outcome after surgery. In addition,
immunosuppressive regimens may contribute to accelera-
tion of the atherosclerotic process in these patients by
exacerbating certain risk factors, eg, hyperglycemia, hyper-
tension, and hyperlipidemia.10,12-14 Impaired wound heal-
ing and increased risk for infection related to immune
system suppression may contribute to adverse effects on
limb and patient survival.10 In addition, a vascular anasto-
mosis to the external iliac artery potentially could compro-
mise distal flow in that extremity and affect graft patency.
Previous studies have demonstrated the efficacy of bypass
procedures to treat limb-threatening ischemia in patients
with renal transplants.9,15-19 These reports have generally
included small numbers of patients grouped with patients
with ESRD. To date, the present study is the largest re-
ported series of infrainguinal revascularization in patients
with functioning renal allografts. The purpose of the study
was to evaluate outcome, ie, graft patency, limb salvage,
and survival, in patients undergoing infrainguinal revascu-
larization.
PATIENTS AND METHODS
Data prospectively entered into our vascular registry
were reviewed for all lower extremity bypass procedures
performed from January 1, 1990, through January 31,
2002. A full-time database manager who enters informa-
tion regarding patient demographics, surgical indications,
procedures, and complications as they occur manages the
database. Every patient medical record was also reviewed.
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Institutional review board approval was obtained before the
study. Sixty patients were identified who had a functioning
renal allograft at infrainguinal revascularization. Patients
were excluded if they required dialysis at the time of sur-
gery.
Patient demographic data and preoperative risk factors
were evaluated, including age, sex, smoking status, conges-
tive heart failure, and history of coronary artery disease.
Our database prospectively defined renal allograft dysfunc-
tion as preoperative serum creatinine concentration (SCr)
greater than 2.0 mg/dL but not requiring dialysis. Patients
who had undergone combination kidney-pancreas trans-
plantation were identified. In addition, patients were eval-
uated with regard to side on which the renal transplant was
placed.
Vascular fellows and general surgery residents per-
formed all procedures under the direct supervision of staff
vascular surgeons. Patient follow-up consisted of routine
office visits, and bypass graft surveillance included assess-
ment with physical examination, ankle-brachial index, and
duplex imaging or angiography when patency of the graft
was in question. Routine graft surveillance was not per-
formed. Postoperative outcome assessment included anal-
ysis of complications, primary graft patency, limb salvage,
and survival. For patients who died, date of death was
obtained from the registry or from the online Social Secu-
rity Death Index Database.20
Statistical analysis was performed with StatView soft-
ware (version 5.0; SAS Institute, Cary, NC). Survival, pa-
tency and limb salvage analysis was performed with the
Kaplan-Meier product-limit method. The resulting survival
curves were compared with the Cox-Mantel log-rank test,
with significant difference assumed at P  .05.
RESULTS
Sixty renal transplant recipients underwent 76 bypass
procedures in 71 limbs. Forty patients (67%) were men, and
20 patients were women (33%), with age range from 30 to
74 years (mean, 47 years). Mean follow-up was 25.1
months.
Comorbid conditions included diabetes (98%), coro-
nary artery disease (43%), hypertension (78%), and smok-
ing (70%) (Table I). Impaired allograft function (SCr2.0
mg/dL) was present at bypass in 11 procedures (14%).
Lower extremity revascularization was performed on the
same side of the body as renal transplantation in 41 proce-
dures (57%). Five patients (8%) received a combined kid-
ney-pancreas transplant. All patients underwent preopera-
tive water-soluble contrast angiography.
Indications for surgery included tissue loss, evidenced
by gangrene or nonhealing ulceration in 70 procedures
(92%), rest pain in 2 procedures (3%), and claudication in 4
procedures (5%).
Inflow and outflow vessels used for each bypass proce-
dure are shown in Table II. Thirty-eight inflow anastomo-
ses (50%) were to the femoral artery. Seventy-five outflow
anastomoses (99%) were performed to vessels below the
knee. Autogenous vein was used in most bypass procedures
(96%), but in 3 procedures either prosthetic vein or com-
posite vein–-prosthetic vein was used (Table III).
Postoperative complications are detailed in Table IV.
There were 9 major complications (11.8%), including 1
postoperative myocardial infarction and 5 early (within 30
days) graft failures. Four grafts were salvaged with early
operative revision, but below-knee amputation was neces-
sary in 1 patient. In addition, in 1 patient with preoperative
renal insufficiency renal failure developed, requiring hemo-
dialysis.
Thirty-day mortality rate was 1.3% (1 patient). Overall
survival at 1 year was 93.4% 2.9%, at 3 years was 84.6%
Table 1. Patient data and preoperative risk factors
Patients
n %
Male 40 67
Female 20 33
Diabetes 59 98
Congestive heart failure 11 18
Coronary artery disease 26 43
Creatinine 2.0 mg/dL 7 12
Smoking 43 71
Hypertension 47 78
Stroke 6 10
Table 2. Bypass conduit
Patients (n) Procedures (%)
Inflow artery
Femoral 38 50.0
Suprageniculate popliteal 11 14.5
Infrageniculate popliteal 19 25.0
Posterior tibial 2 2.6
Vein graft 4 5.2
Prosthetic graft 2 2.6
Outflow artery
Suprageniculate popliteal 1 1.3
Infrageniculate popliteal 12 15.7
Tibioperoneal trunk 3 3.9
Anterior tibial 13 17.1
Dorsalis pedis 22 28.9
Posterior tibial 12 15.7
Peroneal 5 6.5
Tarsal 6 7.9
Previous vein graft 2 2.6
Table 3. Conduit material
Patients (n) Procedures (%)
Nonreversed saphenous vein 31 40.7
In situ saphenous vein 17 22.3
Reversed saphenous vein 12 15.7
Arm vein 9 11.8
Composite vein-vein 4 5.2
Composite vein-prosthetic vein 2 2.6
Prosthetic vein 1 1.3
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4.3%, and at 5 years was 67.4%  6.8%. Renal allograft
dysfunction (SCr2.0 mg/dL) was associated with signif-
icantly diminished survival (P .01, log-rank test). Survival
in patients with preoperative SCr 2.0 mg/dL was 90.9%
 8.7% at 1 year, 45.5% 15% at 3 years, and 34.1% 15%
at 5 years, versus 93.8% 3%, 86.8% 4.4%, and 73.6%
7.2%, respectively, in patients with SCr 2.0 mg/dL (Fig
1).
Kaplan-Meier survival curves are shown for limb sal-
vage in Figure 2 and for primary graft patency in Figure 3.
Primary graft patency at 1 year was 77.9% 5.3%, at 3 years
was 65.6%  7.5%, and at 5 years was 43.7%  13.6%.
Presence of a renal allograft anastomosis to the external iliac
artery on the same side as the lower extremity bypass graft
was not associated with decreased graft patency (P  .84).
There was no significant difference in limb salvage or
patency in patients with kidney-pancreas transplants, al-
though the number of patients in this group was too small
(n  5) to derive a significant conclusion. The type of
conduit used, eg, reversed saphenous vein, nonreversed
saphenous vein, in situ saphenous vein, arm vein, prosthetic
vein, or composite vein–prosthetic vein, had no significant
effect on graft patency or limb salvage. Furthermore, nei-
ther length nor inflow or outflow site of the graft anasto-
mosis had a significant effect on patency or limb salvage.
Limb salvage at 1 year was 86.5%  4.) %, at 3 years was
81.9%  4.6, and at 5 years was 78.2%  5.7%. Fourteen
limbs in 12 patients ultimately underwent amputation after
bypass grafting. In 6 of these limbs (42.9%) the bypass graft
was patent at amputation.
DISCUSSION
Poor surgical outcome has been consistently reported
for patients with ESRD who undergo lower extremity
bypass grafting to treat limb-threatening ischemia.6-9,21,22
However, given the high incidence of complications and
poor survival after primary amputation in this population,23
aggressive attempts at revascularization are recommend-
ed.11,22
The effect of a functioning renal allograft on long-term
outcome after lower extremity bypass is unclear. The high
cardiovascular death rate for patients receiving dialysis is
decreased after successful renal transplantation, but still
Table 4. Postoperative complications
Patients (n) Procedures (%)
Myocardial infarction 1 1.3
Renal failure 1 1.3
Graft thrombosis 4 5.2
Hematoma 1 1.3
Lymphocele 1 1.3
Amputation 1 1.3
Fig 1. Patient survival after infrainguinal revascularization.
Dashed line, Survival for patients with renal allograft insufficiency;
solid line, survival for patients without renal allograft insufficiency
(creatinine concentration 2.0 mg/dL; P  .01). Standard error
was less than 10% at all points.
Fig 2. Limb survival after infrainguinal revascularization. Stan-
dard error was less than 10% at all points.
Fig 3. Graft patency after infrainguinal revascularization. Stan-
dard error was less than 10% at all points.
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exceeds that for patients in the highest risk group after
myocardial infarction.3 In addition to accelerated athero-
sclerosis associated with diabetic and hypertensive ne-
phropathy,16 immunosuppressive therapy further increases
cardiovascular risk. Nevertheless, overall patient survival is
improved after renal transplantation.1
The natural history of lower extremity vascular disease
after infrainguinal revascularization in renal transplant re-
cipients has not been well studied. A few studies have
reported on efficacy of bypass procedures in patients after
renal transplantation9,15,16; however, these reports have
included small numbers of patients who were grouped with
patients receiving dialysis.
This study was performed to determine outcome of
infrainguinal revascularization in patients with functioning
renal allografts. Although most patients in our study pop-
ulation had diabetes (98%), excellent overall patient sur-
vival was achieved. Survival at 1 year was 93%, and at 5 years
was 85%, which compares favorably with previously pub-
lished survival rates for patients with diabetes undergoing
renal transplantation. In a series of 91,021 renal transplants
based on the United Network for Organ Sharing registry,
survival in patients with type I diabetes was 92.7% at 1 year
and 84.5% at 3 years, compared with 91.3% at 1 year and
82.5% at 3 years in patients with type II diabetes.24
Our group recently published the results of a series of
177 infrainguinal bypass procedures in 146 patients receiv-
ing dialysis.11 Whereas 30-day mortality (3% vs 1.3%) and
3-year limb salvage (80% vs 82%) were comparable in our
patients with ESRD receiving dialysis and patients with a
functioning renal transplant, overall 3-year survival rate was
only 18% for patients receiving dialysis. This appears far
worse than the survival rate of 85% at 3 years in the current
study. Renal transplant recipients are at high risk for car-
diovascular morbidity and mortality related to both previ-
ous status as dialysis recipients and post-transplant factors,
eg, indirect effects of immunosuppression. Improvement in
survival for patients with ESRD after transplantation may
be related to aggressive treatment of risk factors, ie, hyper-
glycemia, hypertension, and hyperlipidemia, after trans-
plantation.12 In addition, renal transplant recipients tend to
be younger, 23 as in this study.
The potential effect of immunosuppression on out-
come after lower extremity bypass grafting is important. On
one hand, infectious complications related to immune sup-
pression could affect both limb salvage and survival after
infrainguinal bypass grafting, especially in a population
with diabetes predominating, as in our study. Survival after
renal transplantation in patients with diabetes is noticeably
poorer than in patients without diabetes.24 On the other
hand, potential benefits of various immunosuppressive
agents, eg, rapamycin, on intimal hyperplasia and graft
patency are currently being studied.25 Inasmuch as immu-
nosuppression regimens have changed dramatically over
the past decade, with great variation among our patients
throughout the 12-year span of the study, we could not
assess the effect of immunosuppression therapy on out-
come after bypass procedures in our patients.
When specific preoperative risk factors were evaluated,
it became clear that patients with renal allograft dysfunction
demonstrated a significant decrease in overall survival. Sur-
vival at 5 years in these patients was only 34%, compared
with 74% in patients without allograft dysfunction. These
data suggest that a well-functioning allograft positively
affects survival. Thus survival rate in patients with kidney
transplant dysfunction more closely approximates that in
patients with ESRD receiving dialysis.
Excellent overall limb salvage was achieved in these
patients. Limb salvage at 3 years was 82%, and at 5 years was
78%. This is similar to limb salvage rates at 2 years, ranging
from 52% to 91% in patients with ESRD.21,22,26 Further-
more, acceptable patency was achieved in this group of
patients. However, as in patients receiving dialysis,9 there
was a high incidence of amputation of limbs with a patent
graft, suggesting that factors in addition to ischemia con-
tribute to limb loss. In our study, in 42% of patients who
ultimately underwent amputation the bypass graft was
patent. Ability to identify patients who will ultimately ben-
efit from revascularization would obviate multiple repeat
operations with associated morbidity, lengthy hospitaliza-
tion, and delayed rehabilitation.
In this group of patients there were no preoperative risk
factors that significantly affected limb salvage or primary
patency. Placement of a bypass graft distal to a previously
placed renal allograft is not associated with a significant
“steal effect,” or decrease in graft patency. Type and con-
figuration of conduit used had no significant effect on
patency, limb salvage, or survival. A high percentage of
bypass procedures were performed with nonreversed sa-
phenous vein (41%). The approach to limb salvage at our
institution is flexible, based on available conduit and type of
bypass graft needed. We have previously reported results of
lower extremity bypass in which we observed no significant
difference in patency between in situ and ex situ vein
grafts.27 The results of the present study are consistent with
our previous findings.
In summary, infrainguinal revascularization can be per-
formed with excellent survival and limb salvage rates in
patients with functioning renal transplants. The importance
of a well-functioning renal allograft was evidenced by sig-
nificant survival disadvantage in patients with even moder-
ate renal insufficiency.
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